Literature DB >> 8054487

Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation.

M A Brown1, D Metcalf, N M Gough.   

Abstract

We have assessed the limitations of the polymerase chain reaction (PCR) as a semiquantitative technique for assessing very low level gene expression. Using PCR, the in vivo expression patterns of the cytokines Leukaemia Inhibitory Factor (LIF) and Interleukin 6 (IL-6) in the normal adult mouse, have been examined. We show that both LIF and IL-6 mRNA are constitutively expressed, albeit at extremely low levels, in most tissues. While it is unclear whether this low level of expression is of biological significance, it is possible that it reflects a local mode of action of these potent polyfunctional molecules. Lipopolysaccharide, the bacterial cell wall product responsible for endotoxic shock, when administered in vivo, was capable of inducing the expression of both LIF and IL-6 in all of the tissues examined. In addition, LIF and IL-6 expression was induced in lung tissue by in vitro culturing in serum-free media. This induction of LIF and IL-6, by LPS and culturing, may reflect the role of these molecules as mediators of the acute phase response to tissue damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054487     DOI: 10.1016/1043-4666(94)90027-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

Review 1.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 2.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques.

Authors:  J L Jankowsky; B E Derrick; P H Patterson
Journal:  Learn Mem       Date:  2000 Nov-Dec       Impact factor: 2.460

4.  Leukaemia inhibitory factor is expressed in rat gastrocnemius muscle after contusion and increases proliferation of rat L6 myoblasts via c-Myc signalling.

Authors:  Ratchakrit Srikuea; Karyn A Esser; Chumpol Pholpramool
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-08       Impact factor: 2.557

5.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Pulmonary edema and pleural effusion in norepinephrine-stimulated rats--hemodynamic or inflammatory effect?

Authors:  Beate Rassler; Christian Reissig; Wilfried Briest; Andrea Tannapfel; Heinz-Gerd Zimmer
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

7.  Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine.

Authors:  L R Banner; P H Patterson; A Allchorne; S Poole; C J Woolf
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

8.  Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.

Authors:  Junya Kanda; Tatsuki Uchiyama; Naohisa Tomosugi; Masato Higuchi; Takashi Uchiyama; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2009-11-14       Impact factor: 2.490

9.  A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.

Authors:  Michaela Nygårdas; Henrik Paavilainen; Nadine Müther; Claus-Henning Nagel; Matias Röyttä; Beate Sodeik; Veijo Hukkanen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

10.  Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.

Authors:  Julieta Aisemberg; Claudia A Vercelli; María V Bariani; Silvia C Billi; Manuel L Wolfson; Ana M Franchi
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.